Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast Buccal Film in Mild to Moderate Alzheimer's Disease
NCT03402503Phase 2Completed
- Sponsor
- IntelGenx
- Start
- Nov 2018
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of montelukast in Alzheimer's disease (AD), sponsored by IntelGenx. Started Nov 2018; status: completed.
02
Drugs
montelukast
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03402503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03402503.